AngelMed Announces FDA Approval of the Enhanced Real-Time Cardiac Monitor for Acute Coronary Syndrome (ACS) Events
Retrieved on:
Monday, June 28, 2021
The AngelMed Guardian System is the world's first implantable cardiac detection monitor and patient-warning system for acute coronary syndrome (ACS) events, including silent heart attacks.
Key Points:
- The AngelMed Guardian System is the world's first implantable cardiac detection monitor and patient-warning system for acute coronary syndrome (ACS) events, including silent heart attacks.
- "The improved AngelMed Guardian devicewill have a meaningful effect on the current standard of patient cardiology care for ACS events.
- Angel Medical Systems maintains a robust portfolio of U.S. patents relating to detecting cardiac events, including silent heart attacks.
- Implanted monitor alerting to reduce treatment delay in patients with acute coronary syndrome events.